ConductScience.org, home

Paper36364196

Progression of Antiviral Agents Targeting Viral Polymerases.

Peng S and 3 others. Molecules, 2022. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Progression of Antiviral Agents Targeting Viral Polymerases. Papers, record 36364196. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36364196

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Progression of Antiviral Agents Targeting Viral Polymerases.
PubMed
Journal
Molecules
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
1.82
iCite
Revised in PubMed
2024-09-07
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Peng SSiqi
2Wang HHuizhen
3Wang ZZhengtao
4Wang QQingzhonghttps://orcid.org/0000-0001-7472-996X

Source PubMed

Download CSV of authors

Topics2

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
DNA-Directed RNA PolymerasesMajor topic

References149

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133712437Long-term serological, virological and histological responses to RNA inhibition by ARC-520 in Chinese chronic hepatitis B patients on entecavir treatment.Gut2022https://conductscience.org/library/papers/33712437PubMed
212719561A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation.J Virol2003https://conductscience.org/library/papers/12719561PubMed
332326119FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit Replication of Multiple Flaviviruses in Vero Cells.Microorganisms2020https://conductscience.org/library/papers/32326119PubMed
421180544Therapeutic implications of hepatitis C virus resistance to antiviral drugs.Ther Adv Gastroenterol2009https://conductscience.org/library/papers/21180544PubMed
522185586Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase.J Med Chem2012https://conductscience.org/library/papers/22185586PubMed
627084036Attacking hepatitis B virus cccDNA--The holy grail to hepatitis B cure.J Hepatol2016https://conductscience.org/library/papers/27084036PubMed
733524090Antiviral drug discovery: preparing for the next pandemic.Chem Soc Rev2021https://conductscience.org/library/papers/33524090PubMed
833945951Structure and function of SARS-CoV-2 polymerase.Curr Opin Virol2021https://conductscience.org/library/papers/33945951PubMed
98794733Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase.Biochemistry1996https://conductscience.org/library/papers/8794733PubMed
103039890Neurologic manifestations of infection with human immunodeficiency virus. Clinical features and pathogenesis.Ann Intern Med1987https://conductscience.org/library/papers/3039890PubMed
1124623983Approaches to hepatitis C treatment and cure using NS5A inhibitors.Infect Drug Resist2014https://conductscience.org/library/papers/24623983PubMed
1221507964Replication-coupled and host factor-mediated encapsidation of the influenza virus genome by viral nucleoprotein.J Virol2011https://conductscience.org/library/papers/21507964PubMed
1323022351Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection.Antiviral Res2012https://conductscience.org/library/papers/23022351PubMed
1432283108Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites.Antiviral Res2020https://conductscience.org/library/papers/32283108PubMed
1532601157HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/32601157PubMed
1634040117The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials.Sci Rep2021https://conductscience.org/library/papers/34040117PubMed
1723737047Introduction: the structural basis of virus function.Subcell Biochem2013https://conductscience.org/library/papers/23737047PubMed
1827992102Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding.Chembiochem2017https://conductscience.org/library/papers/27992102PubMed
1923436652Structural and functional characterization of K339T substitution identified in the PB2 subunit cap-binding pocket of influenza A virus.J Biol Chem2013https://conductscience.org/library/papers/23436652PubMed
2029946345IMP/GTP balance modulates cytoophidium assembly and IMPDH activity.Cell Div2018https://conductscience.org/library/papers/29946345PubMed

See all 149 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42769543The kynurenine pathway in RNA virus infection: immunometabolic control of antiviral defense and viral persistence.Front Immunol2026https://conductscience.org/library/papers/42769543PubMed
42549298Assessing Renal Dysfunction Incidence Related to Intravenous Acyclovir Usage.Sultan Qaboos Univ Med J2026https://conductscience.org/library/papers/42549298PubMed
42406005Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough.Ther Innov Regul Sci2026https://conductscience.org/library/papers/42406005PubMed
40455163Targeting Key Stages of the Viral Entry and Life Cycle: A Comprehensive Overview of the Mechanisms of Antiviral Actions.Methods Mol Biol2025https://conductscience.org/library/papers/40455163PubMed
40210872Novel derivatives of brincidofovir and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine inhibit orthopoxviruses and human adenoviruses more potently than brincidofovir.Signal Transduct Target Ther2025https://conductscience.org/library/papers/40210872PubMed
40183963Unlocking the dual power of Charybdis natator shell: antiviral and larvicidal activities.Bioresour Bioprocess2025https://conductscience.org/library/papers/40183963PubMed
40082688Identification of potent multi-target antiviral natural compounds from the fungal metabolites against aspartyl viral polymerases.Sci Rep2025https://conductscience.org/library/papers/40082688PubMed
39860981Advances and Challenges in Antiviral Development for Respiratory Viruses.Pathogens2024https://conductscience.org/library/papers/39860981PubMed
39769063Coumarins and Hesperetin Inhibit Human Respiratory Syncytial Virus Infection.Int J Mol Sci2024https://conductscience.org/library/papers/39769063PubMed
39339151Etravirine Prevents West Nile Virus and Chikungunya Virus Infection Both In Vitro and In Vivo by Inhibiting Viral Replication.Pharmaceutics2024https://conductscience.org/library/papers/39339151PubMed
39125602Distinct Characteristic Binding Modes of Benzofuran Core Inhibitors to Diverse Genotypes of Hepatitis C Virus NS5B Polymerase: A Molecular Simulation Study.Int J Mol Sci2024https://conductscience.org/library/papers/39125602PubMed
39066290Naturally Derived Terpenoids Targeting the 3Dpol of Foot-and-Mouth Disease Virus: An Integrated In Silico and In Vitro Investigation.Viruses2024https://conductscience.org/library/papers/39066290PubMed
39021763Protection of animals against devastating RNA viruses using CRISPR-Cas13s.Mol Ther Nucleic Acids2024https://conductscience.org/library/papers/39021763PubMed
38794231Small Molecule Drugs Targeting Viral Polymerases.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/38794231PubMed
38731287Potential Inhibitors of Lumpy Skin Disease's Viral Protein (DNA Polymerase): A Combination of Bioinformatics Approaches.Animals (Basel)2024https://conductscience.org/library/papers/38731287PubMed
37546653Discovery of Hybrid Thiouracil-Coumarin Conjugates as Potential Novel Anti-SARS-CoV-2 Agents Targeting the Virus's Polymerase "RdRp" as a Confirmed Interacting Biomolecule.ACS Omega2023https://conductscience.org/library/papers/37546653PubMed
36851211A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19.Vaccines (Basel)2023https://conductscience.org/library/papers/36851211PubMed
36770734Current Landscape of Methods to Evaluate Antimicrobial Activity of Natural Extracts.Molecules2023https://conductscience.org/library/papers/36770734PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HCP510866PubTator's text mininghttps://conductscience.org/library/genes/10866NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IL17RB55540PubTator's text mininghttps://conductscience.org/library/genes/55540NCBI Gene
NEU14758PubTator's text mininghttps://conductscience.org/library/genes/4758NCBI Gene
POLD310714PubTator's text mininghttps://conductscience.org/library/genes/10714NCBI Gene
RNASEL6041PubTator's text mininghttps://conductscience.org/library/genes/6041NCBI Gene
SMR3A26952PubTator's text mininghttps://conductscience.org/library/genes/26952NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36364196

GET https://conductscience.org/api/papers/v1/36364196/references?page=2